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Abstract
Background: Most common systems of genetic engineering of mammalian cells are associated with insertional mutagenesis
of the modified cells. Insertional mutagenesis is also a popular approach to generate random alterations for gene discovery
projects. A better understanding of the interaction of the structural elements within an insertional mutagen and the ability
of such elements to influence host genes at various distances away from the insertion site is a matter of considerable
practical importance.
Methodology/Principal Findings: We observed that, in the context of a lentiviral construct, a transcript, which is initiated at
an internal CMV promoter/enhancer region and incorporates a splice donor site, is able to extend past a collinear viral LTR
and trap exons of host genes, while the polyadenylation signal, which is naturally present in the LTR, is spliced out.
Unexpectedly, when a vector, which utilizes this phenomenon, was used to produce mutants with elevated activity of NF-
kB, we found mutants, which owed their phenotype to the effect of the insert on a gene located tens or even hundreds of
kilobases away from the insertion site. This effect did not result from a CMV-driven transcript, but was sensitive to functional
suppression of the insert. Interestingly, despite the long-distance effect, expression of loci most closely positioned to the
insert appeared unaffected.
Conclusions/Significance: We concluded that a polyadenylation signal in a retroviral LTR, when occurring within an intron,
is an inefficient barrier against the formation of a hybrid transcript, and that a vector containing a strong enhancer may
selectively affect the function of genes far away from its insertion site. These phenomena have to be considered when
experimental or therapeutic transduction is performed. In particular, the long-distance effects of insertional mutagenesis
bring into question the relevance of the lists of disease-associated retroviral integration targets, which did not undergo
functional validation.
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Introduction
Insertional mutagenesis is a modification of target DNA via
incorporation of additional bases. Insertion of long DNA
fragments naturally happens during retroviral infection and
transposition of mobile elements. It is also a byproduct of some
common techniques of genetic engineering and gene therapy. In
the latter case, it has been implicated as the cause of therapy-
associated malignancies [1], and serendipitous activation of
growth-promoting genes by insertion of a retroviral vector may
be responsible for successful expansion of genetically engineered
cells in gene therapy patients[2].
Importantly, insertional mutagenesis could be used to generate
pools of randomly genetically-altered cells or organisms for
forward genetics applications. In this case, the mutants with a
phenotype of interest are selected, and the genetic loci tagged by
inserts in such mutants are further investigated as candidate
regulators of the mutant phenotype. For example, the genes at the
sites of retroviral insertions in mouse tumors are treated as likely
oncogenes or tumor suppressors[3].The yield of phenotypically-
detectable mutants is greatly increased when the inserted fragment
carries a strong promoter, which drives transcription of the
adjacent host DNA, and such mutants could be distinguished from
the spontaneous ones by virtue of their dependence on the
promoter function [4]. Overall, insertional mutagenesis provides
an efficient, cost-effective, unbiased and broadly applicable
functional approach to identification of regulators of various
biological processes (discussed elsewhere [4,5]).
In our prior work [4], we relied on retroviral vectors for efficient
delivery of a mutagenic regulated promoter cassette as a means of
generating insertional mutants for gene discovery studies. This was
achieved by placing the regulated promoter internally in a self-
inactivating virus backbone. While the LTRs in such a vector are
transcriptionally inactive following integration, they still retain the
original polyadenylation site, which plays an important role in
preserving the defined structure of the viral transcript. The
presence of the polyadenylation site in the retroviral LTR creates
an apparent problem for the production of fusion transcripts: one
may expect the outbound transcript to be cut and polyadenylated
prior to reaching the host DNA. Possible solutions to this problem
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retroviral LTRs [4], which may create a problem during
production of the virus; removing the polyadenylation signal from
the LTRs [6], which requires very extensive modification of the
vector backbone and may facilitate additional structural changes
during viral replication; or giving up the use of retroviral
backbones in favor of other vectors, such as DNA-based
transposons [7,8].
However, there are some indications that the problem may be
not so serious. First, there are evidence that at least some retroviral
LTRs permit a considerable amount of read-through transcription
[9]. Second, there are reports that polyadenylation signals within
introns could be co-transcriptionally removed and thus rendered
inactive by splicing machinery [10,11]. Therefore, if transcription
continues through the LTR, and the splice donor site ends up
matched with an appropriate splice acceptor, then the polyade-
nylation signal of the LTR could be lost during splicing, and a
stable hybrid transcript encompassing both the vector-and host-
derived sequences could be formed. In the present report, we
describe our experience with a vector design that relies on this
phenomenon and the effect that the elements of this construct
have on genes at a considerable distance from the integration site.
Results
HIV LTR is inefficient in preventing splicing of vector- and
host-derived sequences
To test the prediction that successful pairing of an internal splice
donor site with a host splice acceptor may result in removal of the
LTR-encoded polyadenylation signal, we constructed a vector
(designated pAIM) based on an HIV-1 backbone (Figure 1) that
should be suitable for reversible insertional mutagenesis. In the
plasmid form, the 59-LTR is promoter-competent, while the 39-
LTR is promoter-deficient. During the natural replication cycle,
both LTRs become identical, carrying the inactivating deletion
in the promoter. The presence of Cre recombinase recognition
sites (loxP) in the LTR permits excision of the promoter cassette.
An internal CMV promoter is collinear with the viral genome. It is
followed by the coding region of Pontellina plumata GFP (copGFP)
[12] and an unpaired splice donor site. The region of copGFP
ends with a sequence that codes for picornaviral 2A peptide. When
encountering this sequence, ribosome is known to proceed without
forming a peptide bond. Consequently, two physically separate
peptides could be created from a single open reading frame [13].
If splicing is successful, host exons and, eventually, polyadenyl-
ation signals will be linked to the vector-encoded fragment, and
a host-encoded peptide may be produced. CopGFP, expressed
either from a vector-encoded or a hybrid transcript, is expected
to mark all transduced cells whenever CMV promoter us
functional. The CMV promoter is also preceded by an array of
tetracycline operators. This feature could be used to reversibly
target the promoter for inactivation using tTS, a tetracycline-
controlled transcription silencer constructed by fusing the
tetracycline repressor protein (TetR) with a KRAB silencing
domain (SD
Kid-1) [14].
The vector was used to infect a culture of immortalized mouse
embryonic fibroblasts at a low infection rate (,10%; judged by the
incidence of copGFP-expressing cells), and individual clones were
established. Ten clones that displayed green fluorescence were
chosen for further analysis. Quantitative PCR on their genomic
DNA confirmed single-copy integration (data not shown). We
relied on nested ligation-mediated PCR on the cDNA from these
clones to look for the presence of hybrid transcripts. Prior to
adapter ligation, the cDNA was digested with frequently cutting
enzyme MboI. Due to the presence of an MboI site in the vector
between the splice donor and the 39-LTR, the unspliced transcript
is expected to produce a distinct band, while bands of variable
sizes are expected from the spliced fusion transcripts. Importantly,
out of the ten clones, at least four demonstrated prominent
expression of putative fusion products.
The PCR products corresponding to the four putative fusion
transcripts were sequenced, confirming the presence of both the
host- and vector-derived sequences. Two of the fragments were
unambiguously mapped to unique sequences in mouse genome
and contained precise fusion of the vector sequences to exons of
mouse TSC22D2 and LRBA genes (Figure 2). The precise
maintenance of the exon boundaries confirms splicing as the
mechanism responsible for the production of the hybrid RNAs.
We concluded that in our construct the combination of read-
through transcription and splicing may alleviate the potential
hurdle of polyadenylation site in the modified HIV-1 LTR.
Long-distance transactivation of RIPK1 gene by
insertional mutagenesis
HEK293ZeoTK is a cell line derived from HEK293 that carries
Zeocin-resistance marker and HSV-1 thymidine kinase gene as
two transgenes, each under the control of an NF-kB-depended E-
selectin promoter [15]. The cells represent a convenient system to
screen mutants with alterations in NF-kB pathway: the cells with
active NF-kB could be selected in the presence of Zeocin, or could
be selectively eliminated in the presence of ganciclovir. In this
manner, numerous mutants with either increased or decreased
activity of this pathway have been selected [6,7,8,15,16,17].
Infection of these cells with the construct described in Figure 1
resulted in multiple Zeocin-resistant clones. As expected, the
mutants had constitutively elevated activity of NF-kB, and this
activity, as well as the pattern of Zeocin and ganciclovir resistance,
was readily reverted when the inserted cassettes were removed by
site-specific recombination or shut-down by expression of the tet-
repressor protein (see Figure 3A and Figure 3B for examples). The
observations allowed us to attribute the mutant phenotypes to the
activity of the inserted fragment.
Three of the mutant clones (2B2.1, 2B1.4 and 2B3) attracted
our interest: in each of them a single insert was located in p25
region of chromosome 6. The three mutants behaved identically in
all the tests. Interestingly, RIPK1 gene, which codes for a known
modulator of NF-kB signaling, also maps to 6p25, and mutations
affecting RIPK1 were previously identified in similar screens[7].
However, the inserts in the current study were located consider-
ably further upstream of any known RIPK1 exon. In fact, the
current annotation of the human genome places several other
genes in the close vicinity of the inserts (Figure 4). Nevertheless,
RIPK1 expression was elevated in the mutant clones at the level of
RNA and protein (Figure 5). In contrast, expression of the
products of the neighboring genes, including those closest to the
inserts, was undetectable or unchanged, and their forced
overexpression in naı ¨ve cells failed to affect NF-kB activity
(Figure 6 and data not shown). Importantly, RIPK1 expression
was reduced in the mutants upon physical removal or transcrip-
tional shut-down of the inserted cassette. The latter observation
indicates that the effect is dues to the activity of the inserted
fragment, rather than by destruction of some negative control
elements. Interestingly, the insert orientation differed between the
mutants. Thus, it is highly unlikely that the mutant phenotype
could be accounted for by a vector-derived transcript fusing with
the RIPK1 sequences, and our attempts at detecting such a fusion
transcript were unsuccessful (data not shown).
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dependent on the overexpression of RIPK1, we measured the
activity of NF-kB-dependent luciferase reporter in the presence of
shRNA directedagainstRIPK1.As before [7],inorder to control for
non-specific effects of RNA interference, we used an shRNA against
p53, which is present, but inactivated in these cells. The example in
Figure 7 demonstrates that interference with RIPK1, but not an
unrelated protein (p53), reduced the activity of NF-kBi nt h e
mutants. Therefore, we concluded that the activity of the inserted
cassette caused constitutive activation of NF-kB through up-
regulation of RIPK1 expression without formation of a fusion
transcript.
Discussion
Various structural and biological features of retroviruses make
retroviral vectors useful for studies the properties of mammalian
transcription (e.g. [18]). In the described experiments, we observed
that, despite the presence of a polyadenylation signal, the modified
LTR of HIV-1 fails to efficiently prevent read-through transcription
and accumulation of ensuing fusion transcripts. This is consistent
with observations from other models, where splicing takes
precedence over polyadenylation [10,11]. It is worth noting that
our observation on the efficiency of this process (4 out of 10 cases) is
a conservative one: detection of the hybrid product was contingent
upon the proximity of MboI site and the absence of secondary
structures, which could potentially interfere with RT-PCR, in the
hybrid RNA. Also, accumulation of the hybrid transcript, in
addition to the removal of the LTR, might require trapping of a
functional polyadenylation site in the downstream sequence.
Formation of hybrid RNAs via read-through is considered one of
the major mechanisms of that generates transducing retroviruses
[19]. The classical scheme [19] proposes formation of a read-
through transcript, which originates at the 59-LTR, incorporates an
entire viral genome, and terminates in the adjacent host sequences.
Such a transcript may be incorporated into the viral particle (albeit
inefficiently, because of its size), but, due to the presence of an LTR
in the middle of the RNA, has to undergo extensive re-
arrangements during reverse transcription in order for a transduc-
ing virus to be formed. Our observations suggest that if internal
sequences of a virus or a viral vector could act as splice donors, the
39-LTR could be removed from such a transcript during splicing.
The resulting RNA may retain the packaging signal, and could be
converted into a transducing virus upon a single recombinational
eventduringreverse transcription.Thismaybeespeciallyimportant
forMLV-basedvectors,whichareoftenusedwithoutinactivationof
the LTRs, and which may regain replication potential in the
presence of a natural human retrovirus[20].
The fusion transcripts generated via splicing have an important
difference from the ones generated via read-through alone: the
host sequences are positioned much closer to the 59-end of the
RNA and, hence, are much more likely to be expressed, which
Figure 1. Functional organization of pAIM. The vector is shown in the form of a provirus collinearly integrated in a host gene. The vector is
flanked by promoter-deficient LTRs (‘‘dLTR’’), which harbor Cre-recombinase recognition sites. The immediate early promoter and enhancer region
from human cytomegalovirus (‘‘CMV’’) is preceded by a cluster of tet-operators (‘‘TO’’), which permit suppression of this promoter in the presence ofa
tetracycline-controlled transcription silencer (tTS). The coding region of copGFP (‘‘copGFP’’) ends with the 2A sequence and an unpaired splice donor
(‘‘2A’’ and ‘‘SD’’ respectively). In the scenario shown above the vector, CMV-driven transcript is polyadenylated on the LTR-derived sequence and
encodes only copGFP. In the scenario shown below the vector, transcription continues into the host DNA, and a mature fusion product is produced
by splicing, which removes the LTR sequences. If the open reading frames of copGFP and the host gene coincide, both copGFP and a host protein
could be produced when the RNA is translated.
doi:10.1371/journal.pone.0015832.g001
Figure 2. Identification of the fusion transcripts generated by trans-LTR splicing in two independent clones. The products of nested
ligation-mediated PCR on MboI-digested cDNA were sequenced. As predicted, the clones contain host sequence, followed by an MboI site (GATC)
and the adapter. The 59-end of the transcript is derived from the vector. The junction point corresponds to host intron/exon boundary.
doi:10.1371/journal.pone.0015832.g002
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therapeutic transduction. Consequently, the risk of a combination
of read-through transcription and splicing has to be seriously
considered when vectors are designed for such applications.
At this time we can only speculate about the molecular mech-
anism, which underlies the long-distance effect of the inserts on
RIPK1 expression. Since the effect requires the function of the
CMV fragment and is orientation-independent, it most resem-
bles that of a classical enhancer. The question is how it can act
at such distances and without significantly affecting the genes
between the insertion site and RIPK1? One explanation is that it
generates a widespread continuous signal (e.g. via chromatin
modification) over hundreds of kilobases, but the promoters of
intermediate genes are for some reason irresponsive to that
particular stimulus (e.g. missing recognition sites for the factors
that could sense it). Another explanation, which we find more
plausible, is that the three-dimensional organization of chromo-
some 6 is such that the sites of integration are physically close to
the beginning of RIPK1 gene. This could occur via looping of
a chromosome, a phenomenon, which was characterized in great
detail, for example, in regard to the regulation of proto-oncogene
Myc [21,22]. Interestingly, structural aberrations or retroviral
insertion sites that are located tens to hundreds of kilobases
away from Myc gene are associated with elevated expression of
this gene and are functionally equivalent to the ones occurring
in direct proximity of that gene, but the possibility of their
direct effect on Myc used to be dismissed based on the
assumption that they are positioned too far and the effects of
enhancers cannot ‘‘leapfrog’’ over long distances [23]. Of note,
we failed to detect in the mutant cells expression of the putative
Figure 3. Reversible activation of NF-kB in mutant cells. (A) Reversible pattern of drug resistance in the mutant clone. Mutant clone 2B2.1 was
cultured in Zeo (upper panels) or GCV (lower panels) after infection with Cre (right panels) or the empty vector (left panels). 2.5610
5 cells per 6 cm
plate were treated for a week, and viable cells were visualized by methanol fixation and methylene blue staining. Similar results were observed in
clones 2B1.4 and 2B3. (B) Reversible up-regulation of an NF-kB reporter in the mutant cells. Luciferase reporter assay was used to compare the activity
of NF-kB in 2B2.1 cells transduced with either Cre or an empty vector to that in the parental HEK293ZeoTK cell line. The activity of a transiently
transfected luciferase reporter was normalized for that of co-transfected constitutive beta-galactosidase expression construct. The data is presented
in relative units, with the normalized activity of the reporter in the parental cell line (HEK293ZeoTK) taken as 1. Mutant clones 2B1.4 and 2B3
demonstrated a similar pattern.
doi:10.1371/journal.pone.0015832.g003
Figure 4. Location of inserts in the three mutant clones. A fragment of p25 region of chromosome 6 is shown, indicating the relative positions
of known genes. The inserts are shown as arrows pointing in the direction of the CMV promoter. Approximate distances from the first annotated
exon of RIPK1 are indicated. The drawing in not to scale.
doi:10.1371/journal.pone.0015832.g004
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from an internal promoter [7]. This is consistent with the notion
that the upstream and the internal promoters are subject to dis-
tinct regulatory mechanisms.
Besides providing new insights into transcriptional regulation of
RIPK1, our observations have important implications for the use of
insertional mutagenesis in gene discovery. Insertional mutagenesis
is typically conducted by insertion of a DNA fragment, which
carries a complete potent viral promoter. A common approach
would be to map a large number of insertion sites in the DNA
from a pool of cells enriched for the phenotype of interest, and
then argue that certain genes are significant for this phenotype
because there are more commonly targeted in this pool than what
may be predicted based on random integration. In most cases,
publicly available lists of such genes are quite extensive and do not
undergo individual validation [3]. An obvious drawback of this
approach is that integration is known to be non-random, but there
is no model to account for this bias, and, especially, for possible
variation in this bias as a function of transcriptional state of
individual loci and physiological state of the cell. On top of this,
our experience suggests that even bona fide commonly targeted sites
may be deceptive: the genes truly responsible for the phenotype
could be located at a considerable distance away from the nominal
integration target. Unlike Myc, which is positioned in a ‘‘gene
desert’’ and may be considered the closest known gene even to
relatively distant inserts, the phenomenon presented in this report
takes place in a segment of a chromosome, which is packed with
known or predicted genes. Thus, a purely bioinformatics approach
Figure 5. Examples of regulated expression of RIPK1 in mutant cells. (A) Elevated expression of RIK1 in the mutant clones. RNA was isolated
from mutant clones 2B2.1, 2B1.4 and 2B3, and from the parental HEK293ZeoTK cells, and analyzed by RT-PCR with RIPK1-specific primers (upper
panel). The bottom panel presents results of RT-PCR on the same samples with primers for a housekeeping gene (GAPDH). (B) Dependence of RIPK1
expression in the mutant clones on the presence of the insert. Mutant clones 2B1.2 and 2B1.4 were infected with a Cre-expressing construct or the
respective empty vector control. The cell lysates were compared by Western blotting with polyclonal anti-RIPK1. (C) Dependence of RIPK1 expression
in the mutant clones on the function of the inserted promoter. Mutant clone 2B1.4 infected with a tTS-expressing construct was cultured with or
without doxycycline. The cell lysates were analyzed by Western blotting with polyclonal anti-RIPK1 and compared to those of the parental
HEK293ZeoTK cells.
doi:10.1371/journal.pone.0015832.g005
Figure 6. Activity of NF-kB upon overexpression of genes in the vicinity of inserts compared to parental HEK293ZeoTK cells. NF-e ˆB
dependent luciferase reporter activity was measured after cells were co-transfected with respective expression constructs. Only RIPK1 showed
elevated NF-kB activity.
doi:10.1371/journal.pone.0015832.g006
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would like to argue that veracity of predictions unsupported by
experimental validation cannot be taken for granted.
We have previously constructed insertional mutagens [4] that
relied onthe useof a minimal promoter controlled bybinding sites of
tetracycline transactivator protein (tTA), rather than an enhancer-
containing fragment of CMV. Interestingly, the many mutants
generated by those constructs were always attributable to the
production of the fusion transcript, rather than an enhancer-like
effect ([4] and unpublished data). This observation gives a hope that
onemayproduce amoreaccurategene-discoverysystembycarefully
selecting a promoter that is included in the insertional mutagen.
Similar concerns are valid for inadvertent insertional mutagenesis
during experimental and therapeutic transduction. Indeed, although
somegene therapy patientshavedeveloped cancerfollowing insertion
of the therapeutic construct into or very close to LMO2 gene [24],
another case was associated with an insertion 35 kbps upstream of
(and in an opposite orientation to) the same proto-oncogene [25]. In
this regard, vectors devoid of enhancer elements [26] may offer an
attractive avenue for the design of safer gene-delivery vehicles.
Materials and Methods
Cell culture, drug treatment and viral transduction
All cells were cultured in Dulbecco’s modified Eagle’s medium
with 10% FBS, and 1% penicillin and streptomycin at 37uC in the
presence of 5% CO2. Zeocin and ganciclovir were used as
described earlier [4]. Hygromycin (Roche) was used at 100 mg/ml.
All viruses were packaged in 293T cells (originally known as
293tsA1609neo[27]). Virus-containing media were collected at
48 h, filtered, supplemented with 5 ug/ml Polybrene, and applied
to the target cells for an overnight incubation.
Prior to mutagenesis, HEK293ZeoTK cells were cultured in the
presence of ganciclovir for about a week to remove any pre-
existing mutants with activated NF-kB, and then infected with
virus on 6 cm plate. Medium was changed after 24 h of infection.
Next day the cells were replated into 15 cm plate, where they were
treated with Zeocin for 12 days to select for the mutant clones.
Plasmids
Full length RIPK1 expression construct, shRNA against RIPKI
expressing plasmid and shRNA against p53 were as described [7].
pBabeHygro [28] was used a vector backbone for expression of
Cre recombinase as described [3]. The cDNA for tetracycline-
controlled transcription silencer (tTS), as well as the vector used
for its expression (pLPCX) were from Clontech, Inc. All other
constructs for full-lengths cDNA expression were purchased from
Origene.
Reporter assay and Western Blotting
NF-kB-dependent reporter plasmid (pE-selectin-luciferase) was
transiently transfected using Lipofectamine Plus method (Invitro-
gen), and luciferase activity was measured and normalized for that
of a co-transfected constitutively active a ˆ-galactosidase expression
vector, as described earlier [4].
For the detection of RIPK1 protein, total cell lysates were
prepared from 95% confluent plates and analyzed by the Western
blotting using anti-RIPK1 primary antibodies (BD Transduc-
tion Laboratories), goat anti-mouse secondary antibodies (Sigma)
and SuperSignal chemiluminescent substrate (Thermo Scientific).
Chemiluminescence was recorded using FluoroChem HD2 camera
(Alpha Innotech).
PCR
ThehybridmRNAfragmentswererevealedusingnestedligation-
mediatedPCR.ThecDNApreparedfromindividualinfectedclones
wasdigestedwithMboIand ligatedtoanMboIadapter(constructed
byannealing ofGATCACCTGCCCandCTAATACGACTCAC-
TATAGGGCTCGAGCGGCCGCCCGGGCAGGT to enable
the PCR suppression effect [29]). Subsequently, nested PCR was
done using primers GTFwd1 (ACTCGGATAATACGACGCAC-
GAGA) and AP1 (CCATCCTAATACGACTCACTATAGGGC)
for the first stage, followed by the second stage using GTFwd2
(AAGGCTCAGGAGAGGGCAGAGGAA) and AP2 (ACTCAC-
TATAGGGCTCGAGCGGC). The PCR products were separated
on a gel, excised, and sequenced.
For insert mapping using inverse PCR, MspI- digested genomic
DNA form the mutant clones were circularized by self-ligation,
followed by nested PCR. The first round was conducted with
HTOmspS1 (ACAGTGCAGGGAAAGAATAG) and HTOm-
spAS1 (ATGGTGAATTGATCCCATCTTG) primers; the sec-
ond - with primers HTOmspS2 (TTCGTTGGGAGTGAAT-
TAG) and HTOmspAS2 (CAGGGGAAAGAATAGTAGAC).
The final PCR product was cloned into pCR8/GW/TOPOTA
(Invitrogen) and sequenced.
RIPex1S (CTTCCTGGAGAGTGCAGAAC) and RIPex2AS2
(CTCCATCACCAGGGAGTACTTC) primers were used to
assay RIPK1 mRNA expression by RT-PCR. A housekeeping
gene (GAPDH) was used as an internal control (Forward: GGCT-
CTCCAGAACATCATCCCTGC, Reverse: GGGTGTCGCT-
GTTGAAGTCAGAGG).
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Figure 7. A example of the dependence of NF-kB activity in
mutant cells on the function of RIPK1. Mutant 2B2.1 and parental
HEK293ZeoTK cells were assayed for NF-kB activity using transient
transfection of a luciferase reporter. A decline in the reporter activity
(indicated by the red arrow) resulted from adding an shRNA against
RIPK1 to the transfection mix. An shRNA against p53 (a protein that is
expressed, but is inactivated in these cells) was used as the control.
doi:10.1371/journal.pone.0015832.g007
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